K2M has acquired the exclusive license to a portfolio of 17 issued and pending patents for expandable interbody technology.
K2M has also announced its intent to integrate its 3D-printing technology, Lamellar 3D titanium technology, into new products developed with this intellectual property.
“We are excited to have obtained the exclusive rights to this intellectual property portfolio and look forward to integrating our 3D-printing technology with new expandable spinal devices,” says K2M president and chief executive officer, Eric Major.
K2M recently announced two additions to its expandable portfolio. K2M received 510(k) clearance from the US Food & Drug Administration (FDA) for the Mojave PL 3D expandable interbody system. The company also introduced the Sahara AL expandable stabilisation system, the only lordotic expandable interbody device with integrated screw fixation on the market.
